Live Oak Investment Partners »

Lumos Pharma shares owned by Live Oak Investment Partners

Quarter-by-quarter ownership of Lumos Pharma shares owned by Live Oak Investment Partners from 13F filings

Historical chart of Live Oak Investment Partners investment in Lumos Pharma

Tip: Access up to 7 years of quarterly data

All positions including Lumos Pharma held by Live Oak Investment Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lumos Pharma by Live Oak Investment Partners

Quarter filed Position value Share count Share price at filing
2024-09-30 $43 11 3.91
2024-06-30 $25 11 2.36
2023-12-31 $34 11 3.18
2023-09-30 $35 11 3.27
2023-06-30 $35 11 3.27
2023-03-31 $35 11 3.27
2022-12-31 $39 11 3.55

More positions owned by Live Oak Investment Partners

Janus Short Duration (Principal) (VNLA)
Vanguard Europe Pacific ETF (Principal) (VEA)
Pgx etf (Principal) (PGX)
Ssga Active Etf Tr blkstn gsosrln (Principal) (SRLN)
First Tr Exch Traded Fund Ii lng/sht equity (Principal) (FTLS)
Invesco Exchange Traded Fd T rusel mdcp eql (Principal) (XMHQ)
IQ Hedge Multi-Strategy Tracker (Principal) (QAI)
iShares S&P SmallCap 600 Index (Principal) (IJR)
Vanguard Information Technology ETF (Principal) (VGT)
Apple (Principal) (AAPL)
Netflix (Principal) (NFLX)
Facebook Inc cl a (Principal) (META)
Chevron Corporation (Principal) (CVX)
Amazon (Principal) (AMZN)
Merck & Co (Principal) (MRK)

View all positions for Live Oak Investment Partners

Top funds holding Lumos Pharma

Private Advisor
Renaissance Technologies
Greenwich Wealth Management
Wells Fargo & Company
Geode Capital Management
BlackRock
Dimensional Fund Advisors
Bank of New York Mellon
Wealth Advisors of Iowa
Key FInancial
Paladin Advisory Group
Bank of America Corporation
West Financial Advisors
Advisor Group Holdings
Royal Bank of Canada

View all funds holding Lumos Pharma